126 related articles for article (PubMed ID: 32141094)
1. Risk stratification for central conventional chondrosarcoma of bone: A novel system predicting risk of metastasis and death in the Cancer Registry of Norway cohort.
Thorkildsen J; Taksdal I; Bjerkehagen B; Norum OJ; Myklebust TA; Zaikova O
J Surg Oncol; 2020 Jun; 121(7):1115-1125. PubMed ID: 32141094
[TBL] [Abstract][Full Text] [Related]
2. Chondrosarcoma local recurrence in the Cancer Registry of Norway cohort (1990-2013): Patterns and impact.
Thorkildsen J; Norum OJ; Myklebust TA; Zaikova O
J Surg Oncol; 2021 Feb; 123(2):510-520. PubMed ID: 33314135
[TBL] [Abstract][Full Text] [Related]
3. Chondrosarcoma in Norway 1990-2013; an epidemiological and prognostic observational study of a complete national cohort.
Thorkildsen J; Taksdal I; Bjerkehagen B; Haugland HK; Børge Johannesen T; Viset T; Norum OJ; Bruland Ø; Zaikova O
Acta Oncol; 2019 Mar; 58(3):273-282. PubMed ID: 30632866
[TBL] [Abstract][Full Text] [Related]
4. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
Schneiderman BA; Kliethermes SA; Nystrom LM
Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
[TBL] [Abstract][Full Text] [Related]
5. Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones.
Dierselhuis EF; Goulding KA; Stevens M; Jutte PC
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD010778. PubMed ID: 30845364
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors of patients with spinal chondrosarcoma: a retrospective analysis of 98 consecutive patients in a single center.
Yin H; Zhou W; Meng J; Zhang D; Wu Z; Wang T; Wang J; Wang P; Shi X; Wu S; Zhao J; Xiao J
Ann Surg Oncol; 2014 Oct; 21(11):3572-8. PubMed ID: 24833099
[TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of the prognosis of 37 chondrosarcoma patients.
Yang ZM; Tao HM; Ye ZM; Li WX; Lin N; Yang DS
Asian Pac J Cancer Prev; 2012; 13(4):1171-6. PubMed ID: 22799300
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of Primary and Recurrent Chondrosarcoma of the Rib.
Roos E; van Coevorden F; Verhoef C; Wouters MW; Kroon HM; Hogendoorn PC; van Houdt WJ
Ann Surg Oncol; 2016 Mar; 23(3):811-7. PubMed ID: 26498768
[TBL] [Abstract][Full Text] [Related]
9. Pelvic chondrosarcomas: surgical treatment options.
Deloin X; Dumaine V; Biau D; Karoubi M; Babinet A; Tomeno B; Anract P
Orthop Traumatol Surg Res; 2009 Oct; 95(6):393-401. PubMed ID: 19801212
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for survival and local control in chondrosarcoma of bone.
Fiorenza F; Abudu A; Grimer RJ; Carter SR; Tillman RM; Ayoub K; Mangham DC; Davies AM
J Bone Joint Surg Br; 2002 Jan; 84(1):93-9. PubMed ID: 11837841
[TBL] [Abstract][Full Text] [Related]
11. Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma.
Berend KR; Toth AP; Harrelson JM; Layfield LJ; Hey LA; Scully SP
J Bone Joint Surg Am; 1998 Jan; 80(1):11-7. PubMed ID: 9469303
[TBL] [Abstract][Full Text] [Related]
12. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
13. Advancing patient age is associated with worse outcomes in low- and intermediate-grade primary chondrosarcoma of the pelvis.
Houdek MT; Witten BG; Hevesi M; Griffin AM; Salduz A; Wenger DE; Sim FH; Ferguson PC; Rose PS; Wunder JS
J Surg Oncol; 2020 Mar; 121(4):638-644. PubMed ID: 31989655
[TBL] [Abstract][Full Text] [Related]
14. Management and prognostic significance of pathological fractures through chondrosarcoma of the femur.
Albergo JI; Gaston CL; Jeys LM; Khajuria A; Carter SR; Tillman RM; Abudu AT; Grimer RJ
Int Orthop; 2015 May; 39(5):943-6. PubMed ID: 25711397
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and survival in conventional chondrosarcoma: A single institution review.
Chen YC; Wu PK; Chen CM; Tsai SW; Chen CF; Chen WM
J Chin Med Assoc; 2020 Jul; 83(7):669-673. PubMed ID: 32221156
[TBL] [Abstract][Full Text] [Related]
16. Conventional Primary Central Chondrosarcoma of the Pelvis: Prognostic Factors and Outcome of Surgical Treatment in 162 Patients.
Bus MPA; Campanacci DA; Albergo JI; Leithner A; van de Sande MAJ; Gaston CL; Caff G; Mettelsiefen J; Capanna R; Tunn PU; Jeys LM; Dijkstra PDS
J Bone Joint Surg Am; 2018 Feb; 100(4):316-325. PubMed ID: 29462035
[TBL] [Abstract][Full Text] [Related]
17. Locally recurrent chondrosarcoma of the pelvis and limbs can only be controlled by wide local excision.
Laitinen MK; Parry MC; Le Nail LR; Wigley CH; Stevenson JD; Jeys LM
Bone Joint J; 2019 Mar; 101-B(3):266-271. PubMed ID: 30813783
[TBL] [Abstract][Full Text] [Related]
18. Secondary chondrosarcoma arising from osteochondroma: outcomes and prognostic factors.
Tsuda Y; Gregory JJ; Fujiwara T; Abudu S
Bone Joint J; 2019 Oct; 101-B(10):1313-1320. PubMed ID: 31564158
[TBL] [Abstract][Full Text] [Related]
19. Dedifferentiated chondrosarcoma: A survival analysis of 159 cases from the SEER database (2001-2011).
Strotman PK; Reif TJ; Kliethermes SA; Sandhu JK; Nystrom LM
J Surg Oncol; 2017 Aug; 116(2):252-257. PubMed ID: 28420036
[TBL] [Abstract][Full Text] [Related]
20. Development and external validation of nomograms to predict sarcoma-specific death and disease progression after surgical resection of localized high-grade conventional primary central chondrosarcoma and dedifferentiated chondrosarcoma.
Tsuda Y; Tsoi K; Stevenson JD; Laitinen M; Ferguson PC; Wunder JS; Griffin AM; van de Sande MAJ; van Praag V; Leithner A; Fujiwara T; Yasunaga H; Matsui H; Parry MC; Jeys LM
Bone Joint J; 2020 Dec; 102-B(12):1752-1759. PubMed ID: 33249892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
